These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7520628)

  • 21. Effects of triple therapy of cyclosporine, FK 506, and RS-61443 on allogeneic small bowel transplantation in dogs.
    Nakajima K; Ochiai T; Nagata M; Suzuki T; Gunji Y; Asano T; Shimada H; Isono K
    Transplant Proc; 1993 Feb; 25(1 Pt 1):595-6. PubMed ID: 7679821
    [No Abstract]   [Full Text] [Related]  

  • 22. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract]   [Full Text] [Related]  

  • 23. Surgical complications requiring early relaparotomy after pancreas transplantation: comparison of the cyclosporine and FK 506 eras.
    Humar A; Harmon J; Gruessner A; Kandaswamy R; Granger D; Zheng C; Drangstveit MB; Sutherland D; Gruessner R
    Transplant Proc; 1999; 31(1-2):606-7. PubMed ID: 10083256
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of FK 506 in experimental pancreas transplantation.
    Arita S; Asano T; Kenmochi T; Enomoto K; Ochiai T; Isono K
    Transplant Proc; 1995 Apr; 27(2):1909-12. PubMed ID: 7536980
    [No Abstract]   [Full Text] [Related]  

  • 25. Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation.
    Ketel BL; Turton-Weeks S; Reed K; Barone GW
    Transplant Proc; 1996 Apr; 28(2):899. PubMed ID: 8623453
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolongation of pancreaticoduodenal allograft survival in rats by treatment with FK 506.
    Yamashita T; Maeda Y; Ishikawa T; Ohira M; Nakagawa H; Nagai Y; Park I; Yamamoto Y; Yoshikawa K; Cai R
    Transplant Proc; 1991 Dec; 23(6):3219-20. PubMed ID: 1721414
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental pancreaticoduodenal allotransplantation in litter mate and random mate dogs with or without cyclosporine.
    Nakayama Y; Sato K; Imai K; Takishima T; Osakabe T; Yokota K; Masaki Y; Uchida H; Kakita A
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1683-6. PubMed ID: 1989330
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunosuppressive requirements for small bowel/liver transplantation.
    McAlister V; Grant D; Wall W; Roy A; Ghent C; Zhong R; Duff J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1204-5. PubMed ID: 8442086
    [No Abstract]   [Full Text] [Related]  

  • 29. Reversal of ongoing rejection of allografts by rapamycin.
    Chen HF; Wu JP; Luo HY; Daloze PM
    Transplant Proc; 1991 Aug; 23(4):2241-2. PubMed ID: 1871859
    [No Abstract]   [Full Text] [Related]  

  • 30. Triple versus quadruple induction immunosuppression in pancreas transplantation.
    Wadström J; Brekke B; Wramner L; Ekberg H; Tydén G
    Transplant Proc; 1995 Feb; 27(1):1317-8. PubMed ID: 7878896
    [No Abstract]   [Full Text] [Related]  

  • 31. Tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: the EURO-SPK 3-year results.
    Malaise J; Saudek F; Boucek P; Adamec M; Van Ophem D; Squifflet JP;
    Transplant Proc; 2005; 37(6):2843-5. PubMed ID: 16182828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of FK 506 on abdominal organ cluster transplantation in pigs.
    Kobayashi N; Sakagami K; Orita K
    Transplant Proc; 1991 Dec; 23(6):3275-9. PubMed ID: 1721434
    [No Abstract]   [Full Text] [Related]  

  • 33. Conversion of pancreas transplants to FK 506 from CsA.
    Tesi RJ; Bryer-Ash M; Jaspan J; Byer-Ashe M [corrected to Bryer-Ash M]
    Transplant Proc; 1995 Dec; 27(6):3032-3. PubMed ID: 8539828
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term outcome of cadaveric kidney grafts with triple drug therapy.
    Amemiya H; Suzuki S; Hayashi R; Nakatani T
    Transplant Proc; 1994 Aug; 26(4):2097-8. PubMed ID: 8066683
    [No Abstract]   [Full Text] [Related]  

  • 35. Synergistic effect of cyclosporine and mizoribine on canine pancreas allograft survival.
    Hayashi R; Kenmochi T; Fukuoka T; Suzuki S; Amemiya H
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1585-6. PubMed ID: 1989300
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimal immunosuppression in pancreas transplantation.
    Stratta RJ
    Transplant Proc; 1999; 31(1-2):619-21. PubMed ID: 10083263
    [No Abstract]   [Full Text] [Related]  

  • 37. Pancreatic xenotransplantation in rabbits.
    Gupta RC; Mathur AK; Prasad N; Sharma P
    Transplant Proc; 1996 Jun; 28(3):1414-5. PubMed ID: 8658718
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation.
    Candinas D; Achilleos O; Lee SJ; Dalgic A; Mayer AD; Buckels JA; McMaster P; D'Silva M
    Transplant Proc; 1994 Dec; 26(6):3251-2. PubMed ID: 7527959
    [No Abstract]   [Full Text] [Related]  

  • 39. Porcine small bowel transplantation with rapamycin-based induction immunosuppression and short-course cyclosporine or FK 506 therapy.
    Cohen DS; Fisher RA; Shapiro JH; Goggins WC; Tawes JW; Mills S; Contos M; Ham JM; Schroeder TJ
    Transplant Proc; 1996 Oct; 28(5):2501-5. PubMed ID: 8907923
    [No Abstract]   [Full Text] [Related]  

  • 40. Pancreaticoduodenal allotransplantation with FK 506 in the cynomolgus monkey.
    Ericzon BG; Kubota K; Groth CG; Wijnen R; Tiebosch T; Buurman W; Kootstra G
    Transplant Proc; 1990 Feb; 22(1):72-3. PubMed ID: 1689905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.